“…Disease-related complications seem to be the challenging problem in aging patients with thalassemia who now survive longer than in the past [3,4]. There are many thalassemiarelated complications which are found to increase morbidity and mortality of the disease that includes heart failure [5][6][7], pulmonary hypertension [8][9][10][11], extramedullary hematopoiesis [12][13][14][15], osteoporosis [16,17], cholelithiasis, infections [18][19][20], thrombosis [21][22][23] and endocrinopathies [24,25]. Several studies in the past few years have shown the clinical risk factors for disease-related complications that include: advanced age, anemia, splenectomy, iron overload, severe thalassemia genotypes and iron chelation therapy [9,19,[26][27][28][29][30].…”